Ophthalmology Innovation Summit @ AAO Logo 2013 OIS@AAO
November 14, 2013 | New Orleans, LA
Register

Agenda

6:30AM to 7:30AM
Registration Check-In Breakfast
7:30AM to 7:45AM
Welcome and Chairman’s Opening Remarks, Followed by "2013; Year in Review"

Emmett T. Cunningham Jr. MD PhD MPH, Partner – Clarus Ventures
Gilbert Kliman MD, Managing Director – InterWest Partners
William J. Link PhD, Managing Director – Versant Ventures

7:45AM to 9:21AM
Private Device Company Showcase

Co-Moderators:
Murthy V. Simhambhatla PhD, Senior Vice President – Abbott Medical Group
James Garvey, Chairman & Managing Partner – SV Life Sciences

7:45am-7:53ami-Optics CorporationJeroen Cammeraat, CEO
7:53am-8:01amNotal VisonScott Jones, President
8:01am-8:09amClarity MedicalKeith Mullowney, Chairman & CEO
8:09am-8:17amWaveTec Vision SystemsThomas Frinzi, President & CEO
8:17am-8:25amRefocus GroupMike Judy, President & CEO
8:25am-8:33amPowerVisionBarry Cheskin, President & CEO
8:33am-8:41amAkkoLens International BVMichiel Rombach, CEO
8:41am-8:49amAcuFocusNicholas Tarantino OD, Chief Clinical & Regulatory Officer
8:49am-8:57amClarVista MedicalPaul McLean, President & CEO
8:57am-9:05amSinopsys SurgicalHarry Ross, President & CEO
9:05am-9:13amSensimed AGJean-Marc Wismer, CEO
9:13am-9:21amAvedroDavid Muller PhD, President & CEO
9:21AM to 9:50AM
Morning Refreshment and Networking Break
9:50AM to 11:34AM
Private BioPharma Company Showcase

Co-Moderators:
Theresa GH Heah MD, Director of Brand Management & Global Marketing Ophthalmology – Bayer HealthCare Pharmaceuticals
Neil Levine, Sr. Director, Marketing – Regeneron Pharmaceuticals

9:50am-9:58amAerie PharmaceuticalsVicente Anido Jr. PhD, Chairman & CEO
9:58am-10:06amAmakem TherapeuticsJack Elands, CEO
10:06am-10:14amOcular TherapeutixAmarpreet Sawhney, President & CEO
10:14am-10:22amRXi PharmaceuticalsGeert Cauwenbergh, President & CEO
10:22am-10:30amOphthotech CorporationDavid Guyer, CEO
10:30am-10:38amNeurotechTed Danse, President & CEO
10:38am-10:46amAllegro OphthalmicsVicken Karageozian, Co-Founder & CTO
10:46am-10:54amPanOpticaPaul Chaney, President & CEO
10:54am-11:02amiCo TherapeuticsAndrew Rae, President & CEO
11:02am-11:10amNovaliq GmbHBernhard Günther, CEO
11:10am-11:18amEleven BiotherapeuticsAbbie Celniker, CEO
11:18am-11:26amIcon BioSciencesWilliam S. (Sandy) White, President & CEO
11:26am-11:34amKala PharmaceuticalsGuillaume Pfefer, President & CEO
11:34AM to 11:59AM
Mobile Ophthalmic Technology Showcase

Moderator:
Gilbert Kliman MD, Managing Director – InterWest Partners

11:34am-11:36amGobiquity Mobile HealthMichael Brownell, CEO
11:39am-11:44amDigisightDoug Foster, CEO
11:44am-11:49amCheckedUpRichard Awdeh MD, Founder & CEO
11:49am-11:54amEyeNetraDavid Schafran, Co-Founder & COO
11:54am-11:59amKeepYourSightMarie Alexander, CEO
11:59am -12:06pm
The Ophthalmology Market
"A View from the Public Sector”

Jeffrey Hoffman, Managing Director, Head of West Coast Healthcare Investment Banking – JPMorgan

12:06PM to 12:13PM
Private Funding and Exit Trends

Jonathan Norris, Managing Director – SVB Capital

12:13PM to 12:20PM
US vs. EU
A Venture Perspective

William J. Link PhD, Managing Director – Versant Ventures

12:20PM
Luncheon Commences
1:00PM to 1:25PM
Keynote: Sustaining Innovation in Ophthalmology
“A View From the Top”

David E.I. Pyott, Chairman of the Board & CEO – Allergan

1:25PM to 1:50PM
OIS Innovator Award

Recipients:
Thomas Burns, President & CEO – Glaukos
Richard Hill MD, Co-Founder – Glaukos

1:50PM to 2:00PM
Coffee and Networking
2:00PM
Luncheon Concludes
2:00PM to 2:07PM
Ophthalmic Innovation 2013
“A View from the NEI”

Paul Sieving MD, Director – National Eye Institute, National Institutes of Health

2:07PM to 2:50PM
Ophthalmic Innovation 2013
“A View from the AAO”

David W. Parke MD, CEO – American Academy of Ophthalmology

2:15PM to 2:50PM
Developing an Effective Dialogue with the FDA

Moderator:
Emmett T. Cunningham Jr. MD PhD MPH, Partner – Clarus Ventures

Panel Members:
Wiley A. Chambers MD, Deputy Director of the Division of Transplant and Ophthalmology Products, Center for Drug Evaluation and Research – FDA
Malvina B. Eydelman MD, Director, Division of Ophthalmic, Neurological and Ear, Nose and Throat Devices Office, Device Evaluation Center of Devices and Radiological Health – FDA

2:50PM to 3:20PM
Alternative Financing Strategies

Moderator:
Charles Warden, Managing Director – Versant Ventures

Panel Members:
Luke Duster, Principal – Capital Royalty
Gregory Shearer, Managing Director – Healthios Capital Markets
Brian Demmert, Managing Partner – Armentum Partners
Buzz Benson, Managing Director – Sightline Partners

3:20PM to 3:50PM
EU Commercialization Strategies

Moderator:
Gilbert Kliman MD, Managing Director – InterWest Partners

Panel Members:
Laurent Attias, Head, Global Commercial Strategy – Alcon
David Muller, President & CEO – Avedro
David E.I. Pyott, Chairman of the Board & CEO – Allergan
James Mazzo, Operating Partner – Versant Ventures (Chairman – AcuFocus)
Andy Corley, Venture Partner – Versant Ventures

3:50PM to 4:20 PM
Afternoon Refreshment and Networking Break
4:20PM to 5:00pm
Physician Entrepreneurship in Ophthalmology

Moderator: 
Richard L. Lindstrom MD, Founder & Attending Surgeon – Minnesota Eye Consultants

Panel Members: 
Mark S. Blumenkranz MD, Professor & Chairman of the Department of Ophthalmology – Stanford University 
Eugene de Juan MD, Founder & Vice Chairman – ForSight Labs 
David L. Epstein MD MMM, Joseph A.C. Wadsworth Clinical Professor of Ophthalmology & Chairman of Duke Eye Center – Duke University School of Medicine
Steve Charles MD, CEO – CamPlex
Daniel Durrie MD, Founder & President – Durrie Vision 

5:00PM to 5:30PM
Going Public
Who, When and Why?

Moderator:
David R. Guyer MD, Chief Executive Officer – Ophthotech

Panel Members:
Jeffrey Hoffman, Managing Director, Head of West Coast Healthcare Investment Banking – JPMorgan
Dan Myers, Co-Founder, President & CEO – Alimera Sciences
Nicholas Galakatos PhD, Managing Director – Clarus Ventures
David E. Redlick, Partner & Co-Chair of the Life Sciences Group – WilmerHale
Chris Cooley CFA, Managing Director – Stephens

5:30PM to 5:35PM
Wrap Up and Closing Comments

Emmett Cunningham Jr. MD PhD MPH, Partner – Clarus Ventures
Gilbert Kliman MD, Managing Director – InterWest Partners
William J. Link PhD, Managing Director – Versant Ventures

5:35PM to 7:00PM
Networking Reception